INS and Insulin resistance: Thus, the aim of this study was to assess the suitability of replacing conventional markers used for insulin resistance and dysglycemia (FPG, the homeostasis assessment model for insulin resistance [HOMA-IR] or fasting insulin) with HbA1c in both quantitative and qualitative MetS criteria.